Abstract
3046 Background: Depletion of CD25+ Tregs improves anti-tumor immunity in preclinical models. DD is a recombinant fusion protein of hIL-2 and diptheria toxin fragment that also kills CD25+ T cells....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
